Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)

The summary for the Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed): Through this I-Corps at NIH program Funding Opportunity Announcement (FOA), NIH and CDC provide administrative supplement awards to active SBIR (NIH and CDC) and STTR Phase I (NIH only) grantees/awardees. The I-Corps at NIH mission is to empower entrepreneurs in developing and validating a strategic business model through diverse customer discovery in order to meet unmet clinical needs. I-Corps enables and accelerates the transformation of invention to impact SBIR and STTR Phase I awardees in a no-cost extension are eligible as long as, if selected, their no cost extension covers the entire duration of I-Corps at NIH cohort. The program provides three-member project teams with access to instruction and mentoring to accelerate the translation of technologies currently being developed with NIH and CDC SBIR and STTR funding. It is anticipated that outcomes for the I-Corps teams participating in this program will include significantly refined commercialization plans and well-informed pivots in their overall commercialization strategies. Prospective applicants are strongly encouraged to contact Scientific/Research staff for more information about the program before applying.
Federal Grant Title: Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Education Environment Food and Nutrition Health Income Security and Social Services
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-22-073
Type of Funding: Grant
CFDA Numbers: 93.084, 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.262, 93.273, 93.279, 93.307, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93
CFDA Descriptions: Information not provided
Current Application Deadline: February 2nd, 2024
Original Application Deadline: February 2nd, 2024
Posted Date: November 19th, 2021
Creation Date: November 19th, 2021
Archive Date: March 9th, 2024
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: January 24th, 2022
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PAR-22-073.html
Grant Announcement Contact
NIH OER Webmaster
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants
NCHHSTP Epidemiologic and Economic Modeling for HIV, Viral Hepatitis, STD, and TB
A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released fro...
Improving the Quality of Life of People with HIV Aged 50 Years and Older in the United Sta...
Understanding Infant Feeding Preferences, Practices, and Outcomes for Mothers and other Pa...
PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Rese...
Impact of Japanese Encephalitis Vaccination in Cambodia
Clinical, Epidemiologic and Ecologic Factors Impacting the Burden and Distribution of Monk...
Reduction of Malaria in U.S. Residents Returning from Overseas Travel to Malaria-Endemic C...
More Grants from the National Institutes of Health
ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/U...
ML/AI Tools to Advance Genomic Translational Research (MAGen) - Coordinating Center (UG3/U...
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01...
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01...
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Cli...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com